Wentzwiller, France

Ricardo Schneeberger

This inventor holds 1 USPTO granted patent and 10 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ricardo Schneeberger. Retrieved from https://idiyas.com/inventor/ricardo-schneeberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ricardo Schneeberger: Innovator in Pharmaceutical Compositions

Introduction

Ricardo Schneeberger is a notable inventor based in Wentzwiller, France. He has made significant contributions to the field of pharmaceuticals, particularly in the area of micronization of active agents. His work has implications for the effectiveness and delivery of pharmaceutical compositions.

Latest Patents

Schneeberger holds 1 patent for his innovative process related to pharmaceutical compositions. His patent focuses on a process for micronization of pharmaceutically active agents, which enhances the solubility and bioavailability of medications.

Career Highlights

Ricardo Schneeberger is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to contribute to advancements in drug formulation and delivery systems. His expertise in pharmaceutical sciences has been instrumental in developing new therapeutic solutions.

Collaborations

Throughout his career, Schneeberger has collaborated with esteemed colleagues such as Gerhard Muhrer and Wolfgang Wirth. These partnerships have fostered innovation and have led to the successful development of various pharmaceutical products.

Conclusion

Ricardo Schneeberger's contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare. His work in micronization processes continues to influence the effectiveness of drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…